PMC:7283670 / 65977-66574 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T377","span":{"begin":115,"end":122},"obj":"Disease"},{"id":"T378","span":{"begin":412,"end":419},"obj":"Disease"}],"attributes":[{"id":"A377","pred":"mondo_id","subj":"T377","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"},{"id":"A378","pred":"mondo_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/MONDO_0005047"}],"text":"Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. placebo: 100 mg/d, qn, for 14 days\nExperimental: thalidomide group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. thalidomide: 100 mg/d qn for 14 days"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T592","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T593","span":{"begin":200,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T594","span":{"begin":449,"end":450},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T595","span":{"begin":497,"end":498},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. placebo: 100 mg/d, qn, for 14 days\nExperimental: thalidomide group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. thalidomide: 100 mg/d qn for 14 days"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T196","span":{"begin":28,"end":33},"obj":"Chemical"},{"id":"T197","span":{"begin":36,"end":46},"obj":"Chemical"},{"id":"T198","span":{"begin":123,"end":128},"obj":"Chemical"},{"id":"T199","span":{"begin":219,"end":237},"obj":"Chemical"},{"id":"T200","span":{"begin":313,"end":324},"obj":"Chemical"},{"id":"T201","span":{"begin":325,"end":330},"obj":"Chemical"},{"id":"T202","span":{"begin":333,"end":343},"obj":"Chemical"},{"id":"T203","span":{"begin":420,"end":425},"obj":"Chemical"},{"id":"T204","span":{"begin":516,"end":534},"obj":"Chemical"},{"id":"T205","span":{"begin":561,"end":572},"obj":"Chemical"}],"attributes":[{"id":"A196","pred":"chebi_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A197","pred":"chebi_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A198","pred":"chebi_id","subj":"T198","obj":"http://purl.obolibrary.org/obo/CHEBI_15377"},{"id":"A199","pred":"chebi_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A202","pred":"chebi_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A203","pred":"chebi_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/CHEBI_15377"},{"id":"A204","pred":"chebi_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A205","pred":"chebi_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"}],"text":"Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. placebo: 100 mg/d, qn, for 14 days\nExperimental: thalidomide group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. thalidomide: 100 mg/d qn for 14 days"}

{"project":"LitCovid-sentences","denotations":[{"id":"T652","span":{"begin":239,"end":272},"obj":"Sentence"},{"id":"T653","span":{"begin":273,"end":298},"obj":"Sentence"},{"id":"T654","span":{"begin":299,"end":535},"obj":"Sentence"},{"id":"T655","span":{"begin":536,"end":573},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. placebo: 100 mg/d, qn, for 14 days\nExperimental: thalidomide group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. thalidomide: 100 mg/d qn for 14 days"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2068","span":{"begin":123,"end":128},"obj":"Chemical"},{"id":"2069","span":{"begin":313,"end":324},"obj":"Chemical"},{"id":"2070","span":{"begin":420,"end":425},"obj":"Chemical"},{"id":"2071","span":{"begin":468,"end":474},"obj":"Chemical"},{"id":"2072","span":{"begin":516,"end":534},"obj":"Chemical"}],"attributes":[{"id":"A2068","pred":"tao:has_database_id","subj":"2068","obj":"MESH:D014867"},{"id":"A2069","pred":"tao:has_database_id","subj":"2069","obj":"MESH:D013792"},{"id":"A2070","pred":"tao:has_database_id","subj":"2070","obj":"MESH:D014867"},{"id":"A2072","pred":"tao:has_database_id","subj":"2072","obj":"MESH:D008775"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. placebo: 100 mg/d, qn, for 14 days\nExperimental: thalidomide group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: 40 mg, q12h, for 5 days. thalidomide: 100 mg/d qn for 14 days"}